Botanical species · safety record

Vitis vinifera

The EFSA Compendium of Botanicals holds 3 constituent measurements, 1 adverse-effect record and 1 genotoxicity assay for Vitis vinifera. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Vitis vinifera L.

3Constituent measurements
2Safety records
4Cited sources
2,525Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 2,525 licensed products naming Vitis vinifera as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • Fresh
  • fluid
  • solid

Source material stated

  • Blueberry
  • Buds
  • Dried fruit
  • Dried seed
  • Edible fruit part
  • Florets
  • Flower
  • Flower clusters

What the records describe

Constituents measured

  • Gallic acid2
  • Proanthocyanidins (condensed tannins)1

Plant parts

  • Fruit unspecified2
  • Seed2

Preparations

  • Solvent extraction3
  • Fresh1

Effect types

  • Systemic1

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Gallic acidFruit unspecifiedSolvent extraction≤ 1.57 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Gallic acidFruit unspecifiedSolvent extraction≥ 0.22 Milligram/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)Resolve DOI
Proanthocyanidins (condensed tannins)SeedSolvent extractionColorimetry, Spectroscopy (Spectrometry) and PhotometryResolve DOI

Recorded adverse effects

Adverse effects reported in the source literature, most often in animal or laboratory models at a stated preparation and dose.

EffectTarget tissuePlant partPreparationTest organismTest typeSource
SystemicSeedFreshDog (as animal)Case reportResolve DOI

Genotoxicity testing

Outcomes of genotoxicity assays as recorded in the source. A negative assay is a result under those test conditions, not a clearance.

OutcomeEndpointTestTested organismMetabolic activationSource
Positivegene mutationbacterial reverse mutation assaySalmonella typhimurium (as organism)With and withoutResolve DOI

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Lluis, Laura., Munoz, Monica., Rosa Nogues, M., Sanchez-Martos, Vanessa., Romeu, Marta., Giralt, Montse., Valls, Josep., Sola, Rosa. Toxicology evaluation of a procyanidin-rich extract from grape skins and seeds . Food and chemical toxicology, 2011, vol. 49, no. 6, p. 1450-1454. DOI
  2. Yoon, Soon-Seek., Byun, Jae-Won., Kim, Min-Jeong., Bae, You-Chan., Shin, Yeun-Kyung., Yoon, Sorah., Lee, Garam., Song, Jae-Young. Natural Occurrence of Grape Poisoning in Two Dogs. Journal of veterinary medical science, 2011, vol. 73, no. 2, p. 275-277. DOI
  3. Yamakoshi, J., Saito, M., Kataoka, S., Kikuchi, M. Safety evaluation of proanthocyanidin-rich extract from grape seeds. Food and chemical toxicology, 2002, vol. 40, no. 5, p. 599-607. DOI
  4. Stagos, Dimitrios., Spanou, Chrysa., Margariti, Maria., Stathopoulos, Constantinos., Mamuris, Zissis., Kazantzoglou, Georgios., Magiatis, Prokopios., Kouretas, Demetrios. Cytogenetic effects of grape extracts (Vitis vinifera) and polyphenols on mitomycin C-induced sister chromatid exchanges (SCEs) in human blood lymphocytes . Journal of agricultural and food chemistry, 2007, vol. 55, no. 13, p. 5246-5252. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue